Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 45, 2016 - Issue 7
3,436
Views
116
CrossRef citations to date
0
Altmetric
Original Articles

Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (15)

Chuan-Hua Zhan, Dong-Shen Ding, Wei Zhang, Hong-Liang Wang, Zhe-Yu Mao & Guo-Jun Liu. (2022) The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling. Bioengineered 13:4, pages 8478-8489.
Read now
Xiang Cao, Na Yao, Zidan Zhao, Yue Fu, Yuting Hu, Ping Zhu, Weihai Shi & Liming Tang. (2022) LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway. Bioengineered 13:3, pages 7771-7784.
Read now
Yiran Si, Jian Yue, Zhaoyang Liu, Mo Li, Feng Du, Xue Wang, Zhong Dai, Nanlin Hu, Jie Ju, Songlin Gao, Xiaobing Wang & Peng Yuan. (2021) Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer. International Journal of Nanomedicine 16, pages 1913-1926.
Read now
Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, Fatemeh Ghahremani, Navid Nezafat & Mohammad Hossein Modarressi. (2021) Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model. Human Vaccines & Immunotherapeutics 17:1, pages 22-34.
Read now
Lu Yang, Feng-Ting Dao, Yan Chang, Ya-Zhe Wang, Ling-Di Li, Wen-Min Chen, Ling-Yu Long, Yan-Rong Liu, Jin Lu, Kai-Yan Liu & Ya-Zhen Qin. (2020) Both Methylation and Copy Number Variation Participated in the Varied Expression of PRAME in Multiple Myeloma. OncoTargets and Therapy 13, pages 7545-7553.
Read now
Kate Rittenhouse-Olson. (2020) Letter from the Editor 2020: Annual Summary and Introduction of the Thematic Issue and Guest Editor. Immunological Investigations 49:7, pages 687-691.
Read now
Li Li, Guang-Hui Cheng, Chen Chen, De-Mei Ma & Xin-Chao Deng. (2020) Actin‑like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker. Bioscience, Biotechnology, and Biochemistry 84:6, pages 1160-1167.
Read now
Xin Nie, Cong Liu, Qian Guo, Ming-jun Zheng, Ling-ling Gao, Xiao Li, Da-wo Liu, Lian-cheng Zhu, Juan-juan Liu & Bei Lin. (2019) TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer. Cancer Management and Research 11, pages 839-855.
Read now
Kate Rittenhouse-Olson. (2019) Thematic 2019 Letter from the Editor. Immunological Investigations 48:7, pages 673-679.
Read now
Shi Jin, Shoubo Cao, Aleksei Grigorev, Jianhua Li, Qingwei Meng, Chunyan Wang, Meiyan Feng, Jing Hu, Feng Jiang & Yan Yu. (2018) Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer. Cancer Management and Research 10, pages 2031-2046.
Read now
. (2018) Thematic 2018 Letter from the Editor. Immunological Investigations 47:8, pages 765-769.
Read now
Shi Jin, Shoubo Cao, Jianhua Li, Qingwei Meng, Chunyan Wang, Lei Yao, Yaoguo Lang, Jingyan Cao, Jing Shen, Bo Pan, Jing Hu & Yan Yu. (2018) Cancer/testis antigens (CTAs) expression in resected lung cancer. OncoTargets and Therapy 11, pages 4491-4499.
Read now
Kate Rittenhouse-Olson. (2018) Letter from the Editor June 2018. Immunological Investigations 47:6, pages 543-546.
Read now
. (2017) Letter from the Editor 2017. Immunological Investigations 46:8, pages 759-764.
Read now
Elisabeth J. M. Huijbers & Arjan W. Griffioen. (2017) The revival of cancer vaccines — The eminent need to activate humoral immunity. Human Vaccines & Immunotherapeutics 13:5, pages 1112-1114.
Read now

Articles from other publishers (101)

Cecilia LezcanoAchim A. Jungbluth & Klaus J. Busam. (2023) Immunohistochemistry for PRAME in Dermatopathology. The American Journal of Dermatopathology 45:11, pages 733-747.
Crossref
Chu Xiao, Tao Fan, Yujia Zheng, He Tian, Ziqin Deng, Jingjing Liu, Chunxiang Li & Jie He. (2023) H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. Journal for ImmunoTherapy of Cancer 11:8, pages e005693.
Crossref
Giacomo Oliveira & Catherine J. Wu. (2023) Dynamics and specificities of T cells in cancer immunotherapy. Nature Reviews Cancer 23:5, pages 295-316.
Crossref
Grace Guzman, Karolina Pellot, Megan R. Reed & Analiz Rodriguez. (2023) CAR T-cells to treat brain tumors. Brain Research Bulletin 196, pages 76-98.
Crossref
Yingyu Xu, Xin Xu, Xiaojian Ni, Jiaomeng Pan, MaoPei Chen, Youpei Lin, Zhiying Zhao, Lan Zhang, Ningling Ge, Guohe Song & Juan Zhang. (2023) Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma. Heliyon 9:3, pages e13269.
Crossref
Yu Miao, Yosuke Konno, Baojin Wang, Lin Zhu, Tianyue Zhai, Kei Ihira, Noriko Kobayashi, Hidemichi Watari, Xin Jin, Junming Yue, Peixin Dong & Mingyan Fang. (2023) Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer. Journal of Translational Medicine 21:1.
Crossref
Yuanzhuo Gu, Zhengkui Zhang & Peter ten Dijke. (2023) Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy. Cellular & Molecular Immunology 20:4, pages 318-340.
Crossref
Karlijn de Joode, Sharon Veenbergen, Claudia Kransse, Dian Kortleve, Reno Debets, Ron H J Mathijssen, Arjen Joosse, Marco W J Schreurs & Astrid A M Van der Veldt. (2023) Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report. Journal for ImmunoTherapy of Cancer 11:2, pages e006467.
Crossref
Eun-Seo Lee, Yasuhiro Suzuki, Hideki Tomioka, Hironori Nakagami & Yasufumi Sato. (2023) Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2. The Tohoku Journal of Experimental Medicine 261:3, pages 239-247.
Crossref
Aldo Manuel Alvarez Moran, Pablo Alejandro Ávila Sánchez, Jorge Alejandro Torres Ríos & Lorena Vega Castillo. 2022. Mesothelioma - Diagnostics, Treatment and Basic Research. Mesothelioma - Diagnostics, Treatment and Basic Research.
Zhongen Wu, Mengxuan Yang & Yiou Cao. (2022) Tumor antigens and vaccines in colorectal cancer. Medicine in Drug Discovery 16, pages 100144.
Crossref
Shui-qing Bi, Ya Peng, Zong-dang Wei, Sheng-zhong Yao, Bin Luo, Ying-ying Ge, Xiao-xun Xie, Wei-xia Nong, Chang Liu, Shao-wen Xiao & Qing-mei Zhang. (2022) FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy. Current Medical Science 42:4, pages 803-816.
Crossref
Ning Ma, Huihui Liu, Yang Zhang, Wei Liu, Zeyin Liang, Qian Wang, Yuhua Sun, Lihong Wang, Yuan Li, Hanyun Ren & Yujun Dong. (2022) Identification of CD8+ T-cell epitope from multiple myeloma-specific antigen AKAP4. Frontiers in Immunology 13.
Crossref
Rashmi Gupta, Bimal Prasad Jit, Santosh Kumar, Sandeep Mittan, Pranay Tanwer, M D Ray, Sandeep Mathur, Vanamail Perumal, Lalit Kumar, G K Rath & Ashok Sharma. (2022) Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy. Epigenomics 14:14, pages 865-886.
Crossref
Jie Cui, Yongsheng Chen, Yangpeng Ou, Genglong Liu, Qingquan Wen, Weiyu Zhu, Longfei Liang, Zhen Chen, Hong Yang, Liping Wang & Minghui Wei. (2022) Cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer. Clinical Immunology 240, pages 109045.
Crossref
Costantino Ricci, Emi Dika, Francesca Ambrosi, Martina Lambertini, Giulia Veronesi & Corti Barbara. (2022) Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis. International Journal of Molecular Sciences 23:11, pages 5911.
Crossref
Costantino Ricci, Tania Franceschini, Francesca Giunchi, Marco Grillini, Francesca Ambrosi, Francesco Massari, Veronica Mollica, Maurizio Colecchia & Michelangelo Fiorentino. (2022) Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis. American Journal of Clinical Pathology 157:5, pages 644-648.
Crossref
Zewei Tu, Jie Peng, Xiaoyan Long, Jingying Li, Lei Wu, Kai Huang & Xingen Zhu. (2022) Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis. Frontiers in Immunology 13.
Crossref
Dian Kortleve, Rui M.L. Coelho, Dora Hammerl & Reno Debets. (2022) Cancer germline antigens and tumor-agnostic CD8+ T cell evasion. Trends in Immunology 43:5, pages 391-403.
Crossref
Anna Maria Cesinaro, Simonetta Piana, Alessia Paganelli, Gioia Pedroni, Giacomo Santandrea & Antonino Maiorana. (2021) PRAME expression in cellular neurothekeoma: A study of 11 cases . Journal of Cutaneous Pathology 49:4, pages 338-342.
Crossref
Kang Liu, Li Cheng, Kun Zhu, Jinhu Wang & Qiang Shu. (2022) The cancer/testis antigen HORMAD1 mediates epithelial–mesenchymal transition to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway in lung cancer. Cell Death Discovery 8:1.
Crossref
Antonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, Rachid Abbas, Damien Drubay, Sophie Piperno-Neumann, Olivia Fromigué, Anne Gomez-Brouchet, Françoise Redini, Robin Droit, Cyril Lervat, Natacha Entz-Werle, Hélène Pacquement, Catherine Devoldere, Didier Cupissol, Damien Bodet, Virginie Gandemer, Marc Berger, Perrine Marec-Berard, Marta Jimenez, Gilles Vassal, Birgit Geoerger, Laurence Brugières & Nathalie Gaspar. (2022) Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis. Cancer Research 82:6, pages 974-985.
Crossref
D. S. Kutilin & O. I. Kit. (2022) Relationship between the transcriptional activity of СT-genes and survival in colorectal cancer patients. Siberian journal of oncology 21:1, pages 37-46.
Crossref
Yoshihiko Araki. (2022) Embryos, cancers, and parasites: Potential applications to the study of reproductive biology in view of their similarity as biological phenomena. Reproductive Medicine and Biology 21:1.
Crossref
Chau M. Bui, Sumire Kitahara, Wonwoo Shon, Tatsiana Pukhalskaya & Bruce R. Smoller. (2021) Lack of PRAME Expression in Cutaneous T-Cell Lymphomas. Dermatopathology 9:1, pages 11-16.
Crossref
Johannes P. W. Heidbuechel & Christine E. Engeland. (2021) Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. Journal of Hematology & Oncology 14:1.
Crossref
Scott Raskin, Stacey Van Pelt, Keri Toner, Preethi Bala Balakrishnan, Hema Dave, Catherine M. Bollard & Eric Yvon. (2021) Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia. Molecular Therapy - Methods & Clinical Development 23, pages 296-306.
Crossref
Lina Lin, Weixia Nong, Bin Luo, Yingying Ge, Xia Zeng, Feng Li, Rong Fan, Qingmei Zhang & Xiaoxun Xie. (2021) Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis. Immunity, Inflammation and Disease 9:4, pages 1759-1770.
Crossref
Boheng Liu, Mingbo Wang, Jiawei Dong, Hao Wang & Ziqiang Tian. (2021) Evaluation of Critical Factors of Postoperative Arrhythmia and Preventive Measures of Deep Venous Thrombosis. Journal of Oncology 2021, pages 1-11.
Crossref
Mathilda Jing Chow, Yan Gu, Lizhi He, Xiaozeng Lin, Ying Dong, Wenjuan Mei, Anil Kapoor & Damu Tang. (2021) Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma. Cancers 13:17, pages 4483.
Crossref
Haoyu Ruan, Zhe Wang, Yue Zhai, Ying Xu, Linyu Pi, Jihong Zheng, Yihang Zhou, Cong Zhang, Ruofan Huang, Kun Chen, Xiangyu Li, Weizhe Ma, Zhiyuan Wu, Jie Shen, Xuan Deng, Chao Zhang & Ming Guan. (2021) Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma. iScience 24:9, pages 102972.
Crossref
Xiaoyan Meng, Xueqing Sun, Zhonglong Liu & Yue He. (2021) A novel era of cancer/testis antigen in cancer immunotherapy. International Immunopharmacology 98, pages 107889.
Crossref
Mary E. Lohman, Aaron J. Steen, Roy C. Grekin & Jeffrey P. North. (2021) The utility of PRAME staining in identifying malignant transformation of melanocytic nevi . Journal of Cutaneous Pathology 48:7, pages 856-862.
Crossref
Alexandra Guillén, Katerina Stiborova, Lorenzo Ressel, Laura Blackwood, Riccardo Finotello, Isabel Amores-Fuster, Nimo Jama & David Killick. (2021) Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma. Research in Veterinary Science 137, pages 226-234.
Crossref
N.A. Avdonkina, A.B. Danilova, T.L. Nekhaeva, E.A. Prosekina, N.V. Emelyanova, A.V. Novik, D.V. Girdyuk, G.I. Gafton & I.A. Baldueva. (2021) Clinical and immunological characteristics of sarcomas patients with clonogenic tumors. Immunobiology 226:4, pages 152094.
Crossref
I. N. Mikhaylova, H. M. Treshalina, I. A. Utyashev, M. V. Kiselevsky, A. A. Lushnikova & I. Zh. Shubina. (2021) ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA. Siberian journal of oncology 20:3, pages 98-106.
Crossref
Mingxin Wen, Hui Ren, Shouqiang Zhang, Tao Li, Jiefeng Zhang & Peng Ren. (2021) CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin. Cell Death & Disease 12:7.
Crossref
Chen Chen, Dan Gao, Jinlong Huo, Rui Qu, Youming Guo, Xiaochi Hu & Libo Luo. (2021) Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer. Scientific Reports 11:1.
Crossref
Cecilia Lezcano, Achim A. Jungbluth & Klaus J. Busam. (2021) PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions. Surgical Pathology Clinics 14:2, pages 165-175.
Crossref
Ye-Rin Kim, Ki-Uk Kim, Jung-Hee Lee, Deok-Won Kim, Jae-Heun Chung, Yeong-Dae Kim, Dong-Hoon Shin, Min-Ki Lee, Yong-Il Shin & Sang-Yull Lee. (2021) Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer. Current Oncology 28:3, pages 1927-1937.
Crossref
Helin Zhang, Meng Sun, Jie Wang, Bin Zeng, Xiaoqing Cao, Yi Han, Shuguang Tan & George F. Gao. (2021) Identification of NY-ESO-1157–165 Specific Murine T Cell Receptors With Distinct Recognition Pattern for Tumor Immunotherapy. Frontiers in Immunology 12.
Crossref
Tania Løve Aaes & Peter Vandenabeele. (2020) The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses. Cell Death & Differentiation 28:3, pages 843-860.
Crossref
Tomohiro Aoki, Kerry J. Savage & Christian Steidl. (2021) Biology in Practice: Harnessing the Curative Potential of the Immune System in Lymphoid Cancers. Journal of Clinical Oncology 39:5, pages 346-360.
Crossref
Mei Feng, Zhongwei Zhao, Mengxuan Yang, Jiansong Ji & Di Zhu. (2021) T-cell-based immunotherapy in colorectal cancer. Cancer Letters 498, pages 201-209.
Crossref
Mohamed Adil, Anandraj K. Vaithy.k, Ashok Kumar Pandurangan, Mohammad Waseem & Neesar Ahmed. 2021. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer 24 37 .
Oleg Shuvalov, Alyona Kizenko, Alexey Petukhov, Olga Fedorova, Alexandra Daks, Andrew Bottrill, Anastasiya V. Snezhkina, Anna V. Kudryavtseva & Nikolai Barlev. (2020) SEMG1/2 augment energy metabolism of tumor cells. Cell Death & Disease 11:12.
Crossref
Anna Danilova, Vsevolod Misyurin, Aleksei Novik, Dmitry Girdyuk, Natalia Avdonkina, Tatiana Nekhaeva, Natalia Emelyanova, Nino Pipia, Andrey Misyurin & Irina Baldueva. (2020) Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells. Clinical Sarcoma Research 10:1.
Crossref
Diana Bell, Achim Bell, Renata Ferrarotto, Bonnie Glisson, Yoko Takahashi, Gregory Fuller, Randal Weber & Ehab Hanna. (2020) High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Annals of Diagnostic Pathology 49, pages 151622.
Crossref
Haoyu Ruan, Yihang Zhou, Jie Shen, Yue Zhai, Ying Xu, Linyu Pi, Ruofan Huang, Kun Chen, Xiangyu Li, Weizhe Ma, Zhiyuan Wu, Xuan Deng, Xu Wang, Chao Zhang & Ming Guan. (2020) Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single‐cell transcriptome analysis. Clinical and Translational Medicine 10:8.
Crossref
Luciana Rodrigues Carvalho Barros, Paulo Thiago De Souza‐Santos, Marco Antonio Marques Pretti, Gustavo Fioravanti Vieira, Marcelo Alves De Souza Bragatte, Marcus Fabiano De Almeida Mendes, Martiela Vaz De Freitas, Nicole De Miranda Scherer, Ivanir Martins De Oliveira, Davy Carlos Mendes Rapozo, Priscila Valverde Fernandes, Tatiana De Almeida Simão, Sheila Coelho Soares‐Lima, Mariana Boroni, Luis Felipe Ribeiro Pinto & Martin Hernan Bonamino. (2020) High infiltration of B cells in tertiary lymphoid structures, TCR oligoclonality, and neoantigens are part of esophageal squamous cell carcinoma microenvironment. Journal of Leukocyte Biology 108:4, pages 1307-1318.
Crossref
Xu Yang & Patrick Ryan Potts. (2020) CSAG2 is a cancer‐specific activator of SIRT1. EMBO reports 21:9.
Crossref
Xin Wang, Xiaozhuo Gao, Jiaxun Tian, Rui Zhang, Yun Qiao, Xiangdong Hua & Gang Shi. (2020) LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. Archives of Biochemistry and Biophysics 689, pages 108469.
Crossref
Bin Luo, Xiang Yun, Jing Li, Rong Fan, Wen-wen Guo, Chang Liu, Yong-da Lin, Ying-ying Ge, Xia Zeng, Shui-qing Bi, Wei-xia Nong, Qing-mei Zhang & Xiao-xun Xie. (2020) Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma. Current Medical Science 40:4, pages 719-728.
Crossref
Lukas M. Braun & Robert Zeiser. (2020) Immunotherapy in Myeloproliferative Diseases. Cells 9:6, pages 1559.
Crossref
Ran Wei, Dylan C. Dean, Pichaya Thanindratarn, Francis J. Hornicek, Wei Guo & Zhenfeng Duan. (2020) Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application. Cancer Letters 479, pages 54-60.
Crossref
Zhaolei Cui, Yansong Chen, Minhua Hu, Yingfeng Lin, Shuyu Zhang, Lingying Kong & Yan Chen. (2020) Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer. Clinica Chimica Acta 503, pages 203-209.
Crossref
Zhenbo Hou, Xiao Liang, Xinmei Wang, Ziqiang Zhou & Guilan Shi. (2020) Myeloid‑derived suppressor cells infiltration in non‑small‑cell lung cancer tumor and MAGE‑A4 and NY‑ESO‑1 expression. Oncology Letters.
Crossref
Shanwu Ma, Xiaowei Wang, Zhenrong Zhang & Deruo Liu. (2020) Actin‐like protein 8 promotes cell proliferation, colony‐formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Thoracic Cancer 11:3, pages 526-536.
Crossref
Sepideh Dashti & Zahra Taherian-Esfahani. (2020) Cellular immune responses against cancer-germline genes in cancers. Human Antibodies 28:1, pages 57-64.
Crossref
Zhaoxu Xu, Haichao Tang, Tianshu Zhang, Mingli Sun, Qiang Han, Jiao Xu, Minjie Wei & Zhaojin Yu. (2020) TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy. Life Sciences 241, pages 117171.
Crossref
Jean-François Rossi, Patrice Céballos & Zhao-Yang Lu. (2019) Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells. Cancer Communications 39:1, pages 34.
Crossref
Meysam Moghbeli. (2019) Genetic and molecular biology of breast cancer among Iranian patients. Journal of Translational Medicine 17:1.
Crossref
Fengkai Xu, Shu Zhang, Zhonghe Liu, Jie Gu, Yin Li, Lin Wang, Wei Mao, Qiaoliang Zhu, Huankai Shou, Di Ge & Chunlai Lu. (2019) TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma. BMC Cancer 19:1.
Crossref
Ashkan Safavi, Amirhosein Kefayat, Fattah Sotoodehnejadnematalahi, Mansoor Salehi & Mohammad Hossein Modarressi. (2018) In Silico Analysis of Synaptonemal Complex Protein 1 (SYCP1) and Acrosin Binding Protein (ACRBP) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer. International Journal of Peptide Research and Therapeutics 25:4, pages 1343-1359.
Crossref
Bin Xu, Achim A Jungbluth, Denise Frosina, Bayan Alzumaili, Nathaniel Aleynick, Elzbieta Slodkowska, Kevin Higgins, Alan Ho, Luc Morris, Ronald Ghossein & Nora Katabi. (2019) The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma. Histopathology 75:5, pages 672-682.
Crossref
Ashkan Safavi, Amirhosein Kefayat, Fattah Sotoodehnejadnematalahi, Mansoor Salehi & Mohammad Hossein Modarressi. (2019) Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine. International Immunopharmacology 76, pages 105872.
Crossref
Maryam Pourmaleki, Jonathan H. Young, Nicholas D. Socci, Sarah Chiang, Marcia Edelweiss, Yanyun Li, Mianlei Zhang, Lev Roshal, Dennis S. Chi, Klaus J. Busam, Ingo K. Mellinghoff & Travis J. Hollmann. (2019) Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A. Oncotarget 10:58, pages 6152-6167.
Crossref
Zahra Taherian-Esfahani & Sepideh Dashti. (2019) Cancer-testis antigens: An update on their roles in cancer immunotherapy. Human Antibodies 27:3, pages 171-183.
Crossref
Marisol Salgado-Albarrán, Rodrigo González-Barrios, Lissania Guerra-Calderas, Nicolás Alcaraz, Thalía Estefanía Sánchez-Correa, Clementina Castro-Hernández, Yesennia Sánchez-Pérez, Elena Aréchaga-Ocampo, Alejandro García-Carrancá, David Cantú de León, Luis A. Herrera, Jan Baumbach & Ernesto Soto-Reyes. (2019) The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer. Oncogenesis 8:8.
Crossref
Mai‑Ying Liu, Hang Su, Hua‑Lan Huang & Jing‑Qi Chen. (2019) Cancer stem‑like cells with increased expression of NY‑ESO‑1 initiate breast cancer metastasis. Oncology Letters.
Crossref
Ashkan Safavi, Amirhosein Kefayat, Ardavan Abiri, Elham Mahdevar, Amir Hossein Behnia & Fatemeh Ghahremani. (2019) In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology 112, pages 93-102.
Crossref
Yu-ting Zhou, Juan-juan Qiu, Yao Wang, Peng-cheng Liu, Qing Lv & Zheng-gui Du. (2019) Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer. Frontiers in Oncology 9.
Crossref
Jafar Mahmoudian, Roya Ghods, Mahboobeh Nazari, Mahmood Jeddi-Tehrani, Mohammad Hossein Ghahremani, Nassim Ghaffari-Tabrizi-Wizsy, Seyed Nasser Ostad & Amir-Hassan Zarnani. (2019) PLAC1: biology and potential application in cancer immunotherapy. Cancer Immunology, Immunotherapy 68:7, pages 1039-1058.
Crossref
Wenwu He, Qunlun Yan, Liangmin Fu & Yongtao Han. (2019) A five‑gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma. Oncology Letters.
Crossref
Aldo Manuel Álvarez-Morán & Pablo Ávila-Sánchez. (2019) Panorama epigenético del mesotelioma pleural maligno. NCT Neumología y Cirugía de Tórax 78:4, pages 395-403.
Crossref
Fabio Grizzi, Elena Monica Borroni, Dorina Qehajaj, Sanja Stifter, Maurizio Chiriva-Internati & Ferdinando C. M. Cananzi. 2019. Current Treatment of Retroperitoneal Sarcomas. Current Treatment of Retroperitoneal Sarcomas 21 32 .
Xia Liu & Guangyong Peng. 2019. Handbook of Immunosenescence. Handbook of Immunosenescence 2091 2114 .
Nathalie Melaine, Emmanuelle Com, Pascale Bellaud, Laetitia Guillot, Mélanie Lagarrigue, Nick A. MorriceBlandine Guével, Régis Lavigne, Juan-Felipe Velez de la Calle, Jörg Dojahn & Charles Pineau. (2018) Deciphering the Dark Proteome: Use of the Testis and Characterization of Two Dark Proteins. Journal of Proteome Research 17:12, pages 4197-4210.
Crossref
Mengyuan Li, Zhixian Liu & Xiaosheng Wang. (2018) Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment. Journal of Oncology 2018, pages 1-13.
Crossref
Douae Bensaid, Thibaut Blondy, Sophie Deshayes, Virginie Dehame, Philippe Bertrand, Marc Grégoire, Mohammed Errami & Christophe Blanquart. (2018) Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma. Clinical Epigenetics 10:1.
Crossref
Michelle H. Townsend, Gajendra Shrestha, Richard A. Robison & Kim L. O’Neill. (2018) The expansion of targetable biomarkers for CAR T cell therapy. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Cecilia Lezcano, Achim A. Jungbluth, Kishwer S. Nehal, Travis J. Hollmann & Klaus J. Busam. (2018) PRAME Expression in Melanocytic Tumors. American Journal of Surgical Pathology 42:11, pages 1456-1465.
Crossref
Mei Guo, Chengzhong You & Jun Dou. (2018) Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates. Biomedicine & Pharmacotherapy 107, pages 1318-1325.
Crossref
Yan Xia, Xiaopeng Tian, Juntao Wang, Dongjuan Qiao, Xianhao Liu, Liang Xiao, Wenli Liang, Dongcheng Ban, Junjun Chu, Jiaming Yu, Rongfu Wang, Geng Tian & Mingjun Wang. (2018) Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report. Oncology Letters.
Crossref
Uffe Klausen, Staffan Holmberg, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Inge Marie Svane & Mads Hald Andersen. (2018) Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies. Frontiers in Immunology 9.
Crossref
Guo-Hao Huang, Lei Du, Ningning Li, Ying Zhang, Yan Xiang, Jun-Hai Tang, Shuli Xia, Eric Erquan Zhang & Sheng-Qing Lv. (2018) Methylation-mediated miR-155-FAM133A axis contributes to the attenuated invasion and migration of IDH mutant gliomas. Cancer Letters 432, pages 93-102.
Crossref
Jyothishmathi Swaminathan & Vidya Gopalakrishnan. 2018. Immunotherapy in Translational Cancer Research. Immunotherapy in Translational Cancer Research 143 160 .
Sergey Malchenko, Simone T. Sredni, Jerusha Boyineni, Yingtao Bi, Naira V. Margaryan, Maheedhara R. Guda, Yulia Kostenko, Tadanori Tomita, Ramana V. Davuluri, Kiran Velpula, Mary J.C. Hendrix & Marcelo B. Soares. (2018) Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors. Oncotarget 9:17, pages 13733-13747.
Crossref
Elizabeth A. Griffiths, Pragya Srivastava, Junko Matsuzaki, Zachary Brumberger, Eunice S. Wang, Justin Kocent, Austin Miller, Gregory W. Roloff, Hong Yuen Wong, Benjamin E. Paluch, Linda G. Lutgen-Dunckley, Brandon L. Martens, Kunle Odunsi, Adam R. Karpf, Christopher S. Hourigan & Michael J. Nemeth. (2018) NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome. Clinical Cancer Research 24:5, pages 1019-1029.
Crossref
Jizhong Zhao, Yueqing Wang, Qianjin Liang, Yan Xu & Jianli Sang. (2018) MAGEA1 inhibits the expression of BORIS via increased promoter methylation. Journal of Cell Science.
Crossref
Guangyong Wu, Wei Wang, Yu Liu, Kai Zhuang, Tao Cai, Zhi Fei Wang & Liang Yang. (2018) NY-SAR-35 is involved in apoptosis, cell migration, invasion and epithelial to mesenchymal transition in glioma. Biomedicine & Pharmacotherapy 97, pages 1632-1638.
Crossref
Xia Liu & Guangyong Peng. 2018. Handbook of Immunosenescence. Handbook of Immunosenescence 1 24 .
Kah Keng Wong, Faezahtul Arbaeyah Hussain, Suet Kee Loo & José I. López. (2017) Cancer/testis antigen SPATA19 is frequently expressed in benign prostatic hyperplasia and prostate cancer. APMIS 125:12, pages 1092-1101.
Crossref
Agnieszka E. Karpik, Bruno P. Crulhas, Carolina B. Rodrigues, Gustavo R. Castro & Valber A. Pedrosa. (2017) Aptamer-based Biosensor Developed to Monitor MUC1 Released by Prostate Cancer Cells. Electroanalysis 29:10, pages 2246-2253.
Crossref
Sepideh Faramarzi & Soudeh Ghafouri-Fard. (2017) Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy. Immunotherapy 9:12, pages 1019-1034.
Crossref
Fengju Chen, Yiqun Zhang, Dominick Bossé, Aly-Khan A. Lalani, A. Ari Hakimi, James J. Hsieh, Toni K. Choueiri, Don L. Gibbons, Michael Ittmann & Chad J. Creighton. (2017) Pan-urologic cancer genomic subtypes that transcend tissue of origin. Nature Communications 8:1.
Crossref
Mansi Saxena & Nina Bhardwaj. (2017) Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines. Current Opinion in Immunology 47, pages 35-43.
Crossref
Isabel K. Macdonald, Celine B. Parsy-Kowalska & Caroline J. Chapman. (2017) Autoantibodies: Opportunities for Early Cancer Detection. Trends in Cancer 3:3, pages 198-213.
Crossref
Myung-Ha Song, Ye-Rin Kim, Jae-Ho Bae, Dong-Hoon Shin & Sang-Yull Lee. (2017) A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells. Biochemical and Biophysical Research Communications 484:2, pages 298-303.
Crossref
Hao Li, Nalini Schaduangrat, Saw Simeon & Chanin Nantasenamat. (2017) Computational study on the origin of the cancer immunotherapeutic potential of B and T cell epitope peptides. Molecular BioSystems 13:11, pages 2310-2322.
Crossref
Sophie Rousseaux, Ekaterina Bourova-Flin, Mengqing Gao, Jin Wang, Jian-Qing Mi & Saadi Khochbin. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.